当前位置: 首页 > 期刊 > 《风湿病与关节炎》 > 2018年第12期
编号:13264747
风湿性与非风湿性瓣膜性心脏病所致感染性心内膜炎的流行病学变化及不同治疗策略疗效分析(4)
http://www.100md.com 2018年12月1日 《风湿病与关节炎》 2018年第12期
     [7]HABIB G.Embolicriskin subacute bacterial endocarditis:determinants and role of trans esophageal echocardiography[J].Curr Cardiol Rep,2003,5(2):129-136.

    [8]CHAMBERS J,SANDOE J,RAY S,et al.The infective endocarditis team:recommendations from an international working group[J].Heart,2014,100(7):524-527.

    [9]KANG DH,KIM YJ,KIM SH,et al.Early surgery versus conventional treatment for infective endocarditis[J].N Engl J Med,2012,366(26):2466-2473.

    [10]GULOTTA JC,GABA S,BULUR S,et al.Two-and live/real time three-dimensional transthoracic echocardiographic assessment of infective endocarditis of a valved pulmonary conduit[J].Echocardiography,2015,32(2):361-364.

    [11]ROMANO G,CAROZZA A,DELLA CORTE A,et al.Native versus primary prosthetic valve endocarditis:comparison of clinical features and long-term outcomes in 353 patients[J].J Heart Valve Dis,2004,13(2):200-208.

    [12]FUNAKOSHI S,KAJI S,YAMAMURO A,et al.Impactof early surgery in the active phase on long-term outcomes in left-sided native valve infective endocarditis[J].J Thorac Cardiovasc Surg,2011,142(4):836-842.

    收稿日期:2018-09-11;修回日期:2018-10-18, 百拇医药(王晶晶 张继佳 王超)
上一页1 2 3 4